with Israel so under the pump with Covid (due to the useless Pfizer vax) and diabetes being a leading comorbidity for Covid death, one would think we would here some news since last November's Israel announcement. The Annual Report said nothing new, it seems.
In November, Proteomics International appointed Zotal Ltd as the exclusive distributor for PromarkerD in Israel, a country recognised as a global leader in the life-science industry and renowned for its early adoption of cutting-edge medical technologies. One in eight adults in Israel has diabetes, and the disease is the country’s fifth leading cause of death. Zotal will complete product registration and reimbursement applications for PromarkerD with the Israeli Department of Medical Devices, Ministry of Health and engage with Israeli Key Opinion Leaders for the promotion and early adoption of the test by major hospitals.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)